Alise Reicin is the founder of Tectonic Therapeutic. Tectonic Therapeutic has raised $80M in total funding. Latest round: Series A. Based in Watertown, MA.
Alise Reicin, MD, is the President and Chief Executive Officer of Tectonic Therapeutic, a pre-clinical stage biotechnology company focused on transforming the discovery of novel G-protein-coupled receptor (GPCR)-targeted therapies. The company launched with an $80 million Series A financing in April 2021. Prior to her role at Tectonic, Dr. Reicin was the President of Clinical Development at Celgene.
Full founder directory · Investor directory · Company funding database · Fundraising library